RHA Redensity™ is dynamically different and designed to be resilient enough to adapt to your dynamic facial movements for a look that’s beautiful at rest and flawless in motion. Experience the only FDA-approved hyaluronic acid filler made to smooth dynamic lipstick lines for natural-looking results. To learn more about the RHA® Collection, visit RHACollection.com.
Cathy’s lipstick lines were improved with 0.7 mL of RHA Redensity™, and her dynamic wrinkles and folds in her lower face were improved with 1.5 mL of RHA® 2 and 1 mL of RHA® 3. Images captured before and two weeks after treatment. Results may vary.
Georgia’s lipstick lines were improved with 0.9 mL of RHA Redensity™, and her dynamic wrinkles and folds in her lower face were improved with 2 mL of RHA® 2 and 1.8 mL of RHA® 4. Images captured before and two weeks after treatment. Results may vary.
The RHA® Collection of resilient hyaluronic acid (HA) fillers includes RHA Redensity, RHA® 2, RHA® 3 and RHA® 4.
RHA Redensity™ is for injection into the facial tissue for the correction of moderate to severe dynamic perioral rhytids; and RHA® 2, RHA® 3 and RHA® 4
are for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults 22 or older.
Do not receive if you have a history of multiple severe allergies or severe allergic reactions; if you are allergic to lidocaine or gram-positive bacterial
proteins; or if you have a bleeding disorder.
The most commonly reported side effects included injection-site redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching.
One of the risks with using these products is unintentional injection into a blood vessel, and while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.
Delayed-onset inflammation near the site of dermal filler injections is one of the known side effects associated with dermal fillers. Cases of delayed-onset inflammation have been reported to occur at the treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to being treated or resolved on its own.
Available by prescription only.
RHA-P-002435.2